Statistics from Altmetric.com
The role of β-blockers in preventing cardiovascular complications of non-cardiac surgery is controversial. Early enthusiasm was dampened by accumulating trial data and concerns about the scientific validity of several trials. When studies with uncertain validity are excluded, meta-analyses of randomised trials show that perioperative β-blockers (started within 1 day before surgery) prevent postoperative myocardial infarction (MI), but increase the risks of stroke and death.1 This Danish nationwide cohort study evaluated the association of long-term preoperative β-blocker treatment with mortality and cardiac morbidity after non-cardiac surgery in patients with uncomplicated hypertension.
Population-based healthcare databases were used to conduct …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.